Distinguished in Monomelic Amyotrophy

Vivian E. Drory

6 Weizmann Street, 
Tel Aviv, TA, IL 
Distinguished in Monomelic Amyotrophy
6 Weizmann Street, 
Tel Aviv, TA, IL 
OverviewLocationsClinical Research

Overview

Vivian Drory practices in Tel Aviv, Israel. Ms. Drory is rated as a Distinguished expert by MediFind in the treatment of Monomelic Amyotrophy. Her top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Monomelic Amyotrophy, and Cramp-Fasciculation Syndrome.

Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Monomelic Amyotrophy.

Gender
Female

Locations

6 Weizmann Street, Tel Aviv, TA 64239, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Prospective Study in a Cohort of Amyotrophic Lateral Sclerosis (ALS) Patients Participating in a Phase IIb Drug Study (NCT05357950) to Evaluate the Correlation Between Oculometric Measurements and ALS Functional Rating Scale (ALSFRS-R)
An Prospective Study in a Cohort of Amyotrophic Lateral Sclerosis (ALS) Patients Participating in a Phase IIb Drug Study (NCT05357950) to Evaluate the Correlation Between Oculometric Measurements and ALS Functional Rating Scale (ALSFRS-R)
Enrollment Status: Completed
Publish Date: October 30, 2024
Intervention Type: Other
Open Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofloxacin/Celecoxib Combination in Patients With ALS
Open Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofloxacin/Celecoxib Combination in Patients With ALS
Enrollment Status: Completed
Publish Date: March 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

70 Total Publications

Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications.
Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 12, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Drory's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile